Tapewire

Nasdaq · USD

RIGL

RIGEL PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
2423
SEC CIK
0001034842
Parsed reports
264

Last 12 months

Inside the activity.

0 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202601
Mar 202600
Apr 202600
May 202601
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 23, 2024 Filed Jan 26, 2024 02:17 UTC
Furey Raymond J.EVP, GC, CCO & Corp Sec
GrantEmployee Stock Option (Right to Buy) · Derivative 157,000 $0.00 Strike: $1.27 $0.00
Disclosure

SEC source: 0000905148-24-000309 · form4.xml · derivative · entry 2

Furey Raymond J. · CIK 0001577899 · EVP, GC, CCO & Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,000

Underlying: Common Stock · 157,000 shares

Expires 2034-01-23

F3 · derivative.exercise_date: The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 23, 2024, subject to the Reporting Person's continuous service to the issuer through each such period.

Read SEC document
January 23, 2024 Filed Jan 26, 2024 02:17 UTC
Furey Raymond J.EVP, GC, CCO & Corp Sec
GrantCommon Stock 209,000 $0.00 $0.00
Disclosure

SEC source: 0000905148-24-000309 · form4.xml · nonDerivative · entry 1

Furey Raymond J. · CIK 0001577899 · EVP, GC, CCO & Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 214,000

F1 · shares: The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over three (3) years from February 1, 2024, with the first annual vest occurring on February 1, 2025.

F2 · balance_after: Includes 5,000 shares acquired under the Issuer's stock purchase plan.

Read SEC document
January 23, 2024 Filed Jan 26, 2024 02:16 UTC
Schorno Dean LEVP & Chief Financial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 157,000 $0.00 Strike: $1.27 $0.00
Disclosure

SEC source: 0000905148-24-000306 · form4.xml · derivative · entry 2

Schorno Dean L · CIK 0001509688 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,000

Underlying: Common Stock · 157,000 shares

Expires 2034-01-23

F3 · derivative.exercise_date: The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 23, 2024, subject to the Reporting Person's continuous service to the issuer through each such period.

Read SEC document
January 23, 2024 Filed Jan 26, 2024 02:16 UTC
Schorno Dean LEVP & Chief Financial Officer
GrantCommon Stock 209,000 $0.00 $0.00
Disclosure

SEC source: 0000905148-24-000306 · form4.xml · nonDerivative · entry 1

Schorno Dean L · CIK 0001509688 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 415,519

F1 · shares: The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over three (3) years from February 1, 2024, with the first annual vest occurring on February 1, 2025.

F2 · balance_after: Includes 10,000 shares acquired under the Issuer's stock purchase plan.

Read SEC document
January 23, 2024 Filed Jan 26, 2024 02:17 UTC
RODRIGUEZ RAUL RDirector · CEO, President
GrantEmployee Stock Option (Right to Buy) · Derivative 600,000 $0.00 Strike: $1.27 $0.00
Disclosure

SEC source: 0000905148-24-000308 · form4.xml · derivative · entry 2

RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Stock · 600,000 shares

Expires 2034-01-23

F3 · derivative.exercise_date: The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 23, 2024, subject to the Reporting Person's continuous service to the issuer through each such period.

Read SEC document
January 23, 2024 Filed Jan 26, 2024 02:17 UTC
RODRIGUEZ RAUL RDirector · CEO, President
GrantCommon Stock 400,000 $0.00 $0.00
Disclosure

SEC source: 0000905148-24-000308 · form4.xml · nonDerivative · entry 1

RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,089,523

F1 · shares: The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over three (3) years from February 1, 2024, with the first annual vest occurring on February 1, 2025.

F2 · balance_after: Includes 8,810 shares acquired under the Issuer's stock purchase plan.

Read SEC document
January 23, 2024 Filed Jan 26, 2024 02:17 UTC
Santos David AEVP, Chief Commercial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 157,000 $0.00 Strike: $1.27 $0.00
Disclosure

SEC source: 0000905148-24-000307 · form4.xml · derivative · entry 2

Santos David A · CIK 0001820066 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,000

Underlying: Common Stock · 157,000 shares

Expires 2034-01-23

F3 · derivative.exercise_date: The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 23, 2024, subject to the Reporting Person's continuous service to the issuer through each such period.

Read SEC document
January 23, 2024 Filed Jan 26, 2024 02:17 UTC
Santos David AEVP, Chief Commercial Officer
GrantCommon Stock 209,000 $0.00 $0.00
Disclosure

SEC source: 0000905148-24-000307 · form4.xml · nonDerivative · entry 1

Santos David A · CIK 0001820066 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 363,612

F1 · shares: The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over three (3) years from February 1, 2024, with the first annual vest occurring on February 1, 2025.

F2 · balance_after: Includes 10,000 shares acquired under the Issuer's stock purchase plan.

Read SEC document
May 26, 2023 Filed Jul 12, 2023 22:45 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0001140361-23-034286 · form4.xml · derivative · entry 2

LAPOINTE ANTHONY GREGG · CIK 0001331860 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-05-26

F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 26, 2023 Filed Jul 12, 2023 22:45 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-034286 · form4.xml · nonDerivative · entry 1

LAPOINTE ANTHONY GREGG · CIK 0001331860 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 26, 2023 Filed Jul 12, 2023 22:45 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0001140361-23-034285 · form4.xml · derivative · entry 2

MOOS WALTER H · CIK 0001190272 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-05-26

F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 26, 2023 Filed Jul 12, 2023 22:45 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-034285 · form4.xml · nonDerivative · entry 1

MOOS WALTER H · CIK 0001190272 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,222

F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 26, 2023 Filed Jul 12, 2023 22:45 UTC
Wasman JaneDirector
GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0001140361-23-034288 · form4.xml · derivative · entry 2

Wasman Jane · CIK 0001352455 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-05-26

F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 26, 2023 Filed Jul 12, 2023 22:45 UTC
Wasman JaneDirector
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-034288 · form4.xml · nonDerivative · entry 1

Wasman Jane · CIK 0001352455 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 26, 2023 Filed Jul 12, 2023 22:45 UTC
LYONS GARY ADirector
GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0001140361-23-034287 · form4.xml · derivative · entry 2

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-05-26

F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 26, 2023 Filed Jul 12, 2023 22:45 UTC
LYONS GARY ADirector
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-034287 · form4.xml · nonDerivative · entry 1

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 26, 2023 Filed Jul 12, 2023 22:45 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0001140361-23-034284 · form4.xml · derivative · entry 2

Ali-Jackson Kamil · CIK 0001654337 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-05-26

F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 26, 2023 Filed Jul 12, 2023 22:45 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-034284 · form4.xml · nonDerivative · entry 1

Ali-Jackson Kamil · CIK 0001654337 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,750

F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 26, 2023 Filed Jul 12, 2023 22:45 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0001140361-23-034283 · form4.xml · derivative · entry 2

Kotzin Brian L. · CIK 0001715332 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-05-26

F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 26, 2023 Filed Jul 12, 2023 22:45 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-034283 · form4.xml · nonDerivative · entry 1

Kotzin Brian L. · CIK 0001715332 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 26, 2023 Filed Jul 12, 2023 22:45 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0001140361-23-034282 · form4.xml · derivative · entry 2

HANNAH ALISON L. · CIK 0001645600 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-05-26

F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 26, 2023 Filed Jul 12, 2023 22:45 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-034282 · form4.xml · nonDerivative · entry 1

HANNAH ALISON L. · CIK 0001645600 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,250

F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
February 06, 2023 Filed Feb 7, 2023 21:30 UTC
RODRIGUEZ RAUL RDirector · CEO, President
SaleCommon Stock 20,340 $1.75 $35,595.00
Disclosure

SEC source: 0001140361-23-005036 · form4.xml · nonDerivative · entry 2

RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,680,713

F3 · kind: These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.

Read SEC document
February 02, 2023 Filed Feb 6, 2023 22:41 UTC
Santos David AEVP, Chief Commercial Officer
SaleCommon Stock 5,388 $1.66 $8,945.16
Disclosure

SEC source: 0001140361-23-004733 · form4.xml · nonDerivative · entry 1

Santos David A · CIK 0001820066 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,612

F1 · kind: These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.

Read SEC document
February 02, 2023 Filed Feb 6, 2023 22:40 UTC
Schorno Dean LEVP & Chief Financial Officer
SaleCommon Stock 5,389 $1.66 $8,946.28
Disclosure

SEC source: 0001140361-23-004732 · form4.xml · nonDerivative · entry 1

Schorno Dean L · CIK 0001509688 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 196,519

F1 · kind: These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.

Read SEC document
February 02, 2023 Filed Feb 6, 2023 22:40 UTC SaleCommon Stock 5,389 $1.66 $8,946.28
Disclosure

SEC source: 0001140361-23-004731 · form4.xml · nonDerivative · entry 1

Dummer Wolfgang · CIK 0001749991 · EVP & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,459

F1 · kind: These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.

F2 · balance_after: Includes 10,000 shares acquired under the Issuer's stock purchase plan.

Read SEC document
January 26, 2023 Filed Jan 31, 2023 02:45 UTC GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $2.42 $0.00
Disclosure

SEC source: 0001140361-23-003443 · form4.xml · derivative · entry 1

Dummer Wolfgang · CIK 0001749991 · EVP & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 50,000 shares

Expires 2032-01-24

F1 · shares: The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On January 26, 2023, it was determined that the performance metric had been met.

F2 · derivative.exercise_date: The option was fully vested on January 26, 2023, the date the determination was made that the performance metric had been met.

Read SEC document
January 26, 2023 Filed Jan 31, 2023 02:45 UTC
RODRIGUEZ RAUL RDirector · CEO, President
GrantEmployee Stock Option (right to buy) · Derivative 200,000 $0.00 Strike: $2.42 $0.00
Disclosure

SEC source: 0001140361-23-003442 · form4.xml · derivative · entry 1

RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 200,000 shares

Expires 2032-01-24

F1 · shares: The Reporting Person was granted an option with a performance-based condition with respect to 200,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On January 26, 2023, it was determined that the performance metric had been met.

F2 · derivative.exercise_date: The option was fully vested on January 26, 2023, the date the determination was made that the performance metric had been met.

Read SEC document
January 26, 2023 Filed Jan 31, 2023 02:45 UTC
Schorno Dean LEVP & Chief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 125,000 $0.00 Strike: $1.87 $0.00
Disclosure

SEC source: 0001140361-23-003441 · form4.xml · derivative · entry 3

Schorno Dean L · CIK 0001509688 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2033-01-26

F5 · derivative.exercise_date: The shares of common stock subject to the option vest monthly over four (4) years from the vesting commencement date of January 1, 2023, subject to the Reporting Person's continuous service to the issuer through each such period.

Read SEC document
January 26, 2023 Filed Jan 31, 2023 02:45 UTC
Schorno Dean LEVP & Chief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $2.42 $0.00
Disclosure

SEC source: 0001140361-23-003441 · form4.xml · derivative · entry 2

Schorno Dean L · CIK 0001509688 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 50,000 shares

Expires 2032-01-24

F3 · shares: The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On January 26, 2023, it was determined that the performance metric had been met.

F4 · derivative.exercise_date: The option was fully vested on January 26, 2023, the date the determination was made that the performance metric had been met.

Read SEC document
January 26, 2023 Filed Jan 31, 2023 02:45 UTC
Schorno Dean LEVP & Chief Financial Officer
GrantCommon Stock 63,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-003441 · form4.xml · nonDerivative · entry 1

Schorno Dean L · CIK 0001509688 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,908

F1 · shares: The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over four (4) years from February 1, 2023, with the first annual vest occurring on February 1, 2024.

F2 · balance_after: Includes 10,000 shares acquired under the issuer's stock purchase plan.

Read SEC document
January 26, 2023 Filed Jan 31, 2023 02:45 UTC
Santos David AEVP, Chief Commercial Officer
GrantEmployee Stock Option (right to buy) · Derivative 160,000 $0.00 Strike: $1.87 $0.00
Disclosure

SEC source: 0001140361-23-003439 · form4.xml · derivative · entry 3

Santos David A · CIK 0001820066 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 160,000 shares

Expires 2033-01-26

F5 · derivative.exercise_date: The shares of common stock subject to the option vest monthly over four (4) years from the vesting commencement date of January 1, 2023, subject to the Reporting Person's continuous service to the issuer through each such period.

Read SEC document
January 26, 2023 Filed Jan 31, 2023 02:45 UTC
Santos David AEVP, Chief Commercial Officer
GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $2.42 $0.00
Disclosure

SEC source: 0001140361-23-003439 · form4.xml · derivative · entry 2

Santos David A · CIK 0001820066 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 50,000 shares

Expires 2032-01-24

F3 · shares: The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On January 26, 2023, it was determined that the performance metric had been met.

F4 · derivative.exercise_date: The option was fully vested on January 26, 2023, the date the determination was made that the performance metric had been met.

Read SEC document
January 26, 2023 Filed Jan 31, 2023 02:45 UTC
Santos David AEVP, Chief Commercial Officer
GrantCommon Stock 80,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-003439 · form4.xml · nonDerivative · entry 1

Santos David A · CIK 0001820066 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

F1 · shares: The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over four (4) years from February 1, 2023, with the first annual vest occurring on February 1, 2024.

F2 · balance_after: Includes 10,000 shares acquired under the issuer's stock purchase plan.

Read SEC document
January 26, 2023 Filed Feb 7, 2023 21:30 UTC
RODRIGUEZ RAUL RDirector · CEO, President
GrantEmployee Stock Option (right to buy) · Derivative 600,000 $0.00 Strike: $1.87 $0.00
Disclosure

SEC source: 0001140361-23-005036 · form4.xml · derivative · entry 3

RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Stock · 600,000 shares

Expires 2033-01-26

F4 · derivative.exercise_date: The shares of common stock subject to the option vest monthly over four (4) years from the vesting commencement date of January 1, 2023, subject to the Reporting Person's continuous service to the issuer through each such period.

Read SEC document
January 26, 2023 Filed Feb 7, 2023 21:30 UTC
RODRIGUEZ RAUL RDirector · CEO, President
GrantCommon Stock 300,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-005036 · form4.xml · nonDerivative · entry 1

RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,701,053

F1 · shares: The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over four (4) years from February 1, 2023, with the first annual vest occurring on February 1, 2024.

F2 · balance_after: Includes 9,277 shares acquired under the Issuer's stock purchase plan.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:30 UTC
Santos David AEVP, Chief Commercial Officer
GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $2.42 $0.00
Disclosure

SEC source: 0001140361-22-047667 · form4.xml · derivative · entry 1

Santos David A · CIK 0001820066 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-01-24

F1 · shares: The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On December 28, 2022, it was determined that the performance metric had been met.

F2 · derivative.exercise_date: The option was fully vested on December 28, 2022, the date the determination was made that the performance metric had been met.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:30 UTC
RODRIGUEZ RAUL RDirector · CEO, President
GrantEmployee Stock Option (right to buy) · Derivative 200,000 $0.00 Strike: $2.42 $0.00
Disclosure

SEC source: 0001140361-22-047671 · form4.xml · derivative · entry 1

RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2032-01-24

F1 · shares: The Reporting Person was granted an option with a performance-based condition with respect to 200,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On December 28, 2022, it was determined that the performance metric had been met.

F2 · derivative.exercise_date: The option was fully vested on December 28, 2022, the date the determination was made that the performance metric had been met.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:30 UTC GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $2.42 $0.00
Disclosure

SEC source: 0001140361-22-047669 · form4.xml · derivative · entry 1

Dummer Wolfgang · CIK 0001749991 · EVP & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-01-24

F1 · shares: The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On December 28, 2022, it was determined that the performance metric had been met.

F2 · derivative.exercise_date: The option was fully vested on December 28, 2022, the date the determination was made that the performance metric had been met.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:30 UTC
Schorno Dean LEVP & Chief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $2.42 $0.00
Disclosure

SEC source: 0001140361-22-047668 · form4.xml · derivative · entry 1

Schorno Dean L · CIK 0001509688 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-01-24

F1 · shares: The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On December 28, 2022, it was determined that the performance metric had been met.

F2 · derivative.exercise_date: The option was fully vested on December 28, 2022, the date the determination was made that the performance metric had been met.

Read SEC document
September 14, 2022 Filed Sep 16, 2022 20:15 UTC
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.
GrantEmployee Stock Option (right to buy) · Derivative 81,250 $0.00 Strike: $2.00 $0.00
Disclosure

SEC source: 0001140361-22-033613 · form4.xml · derivative · entry 1

VANCE DOLLY · CIK 0001237676 · EVP Corp. Affairs, G.C., Sect.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,250

Underlying: Common Stock · 81,250 shares

Expires 2029-01-23

F1 · shares: The reporting person was granted an option with a performance-based condition with respect to 81,250 shares of common stock on January 23, 2019. Thus, the exercise price of this option is $2.00 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On September 14, 2022, it was determined that the performance metric had been met.

F2 · derivative.exercise_date: The option was fully vested on September 14, 2022, the date the determination was made that the performance metric had been met.

Read SEC document
September 14, 2022 Filed Sep 16, 2022 20:15 UTC
RODRIGUEZ RAUL RDirector · CEO, President
GrantEmployee Stock Option (right to buy) · Derivative 300,000 $0.00 Strike: $2.00 $0.00
Disclosure

SEC source: 0001140361-22-033612 · form4.xml · derivative · entry 1

RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2029-01-23

F1 · shares: The reporting person was granted an option with a performance-based condition with respect to 300,000 shares of common stock on January 23, 2019. Thus, the exercise price of this option is $2.00 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On September 14, 2022, it was determined that the performance metric had been met.

F2 · derivative.exercise_date: The option was fully vested on September 14, 2022, the date the determination was made that the performance metric had been met.

Read SEC document
September 14, 2022 Filed Sep 16, 2022 20:15 UTC
Schorno Dean LEVP & Chief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 81,250 $0.00 Strike: $2.00 $0.00
Disclosure

SEC source: 0001140361-22-033611 · form4.xml · derivative · entry 1

Schorno Dean L · CIK 0001509688 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,250

Underlying: Common Stock · 81,250 shares

Expires 2029-01-23

F1 · shares: The reporting person was granted an option with a performance-based condition with respect to 81,250 shares of common stock on January 23, 2019. Thus, the exercise price of this option is $2.00 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On September 14, 2022, it was determined that the performance metric had been met.

F2 · derivative.exercise_date: The option was fully vested on September 14, 2022, the date the determination was made that the performance metric had been met.

Read SEC document
June 09, 2022 Filed Jun 13, 2022 20:36 UTC
RODRIGUEZ RAUL RDirector · CEO, President
PurchaseCommon Stock 1,000,000 $0.69 $688,400.00
Disclosure

SEC source: 0001567619-22-012778 · doc1.xml · nonDerivative · entry 1

RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,391,776

F1 · price: The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions ranging from $0.67 to $0.70. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each such separate price.

Read SEC document
May 20, 2022 Filed May 23, 2022 21:50 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $2.01 $0.00
Disclosure

SEC source: 0001140361-22-020308 · form4.xml · derivative · entry 2

MOOS WALTER H · CIK 0001190272 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-05-20

F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 20, 2022 Filed May 23, 2022 21:50 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-020308 · form4.xml · nonDerivative · entry 1

MOOS WALTER H · CIK 0001190272 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,222

F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 20, 2022 Filed May 23, 2022 21:50 UTC
Wasman JaneDirector
GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $2.01 $0.00
Disclosure

SEC source: 0001140361-22-020307 · form4.xml · derivative · entry 2

Wasman Jane · CIK 0001352455 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-05-20

F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 20, 2022 Filed May 23, 2022 21:50 UTC
Wasman JaneDirector
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-020307 · form4.xml · nonDerivative · entry 1

Wasman Jane · CIK 0001352455 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 20, 2022 Filed May 23, 2022 21:50 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $2.01 $0.00
Disclosure

SEC source: 0001140361-22-020306 · form4.xml · derivative · entry 2

LAPOINTE ANTHONY GREGG · CIK 0001331860 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-05-20

F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document
May 20, 2022 Filed May 23, 2022 21:50 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-020306 · form4.xml · nonDerivative · entry 1

LAPOINTE ANTHONY GREGG · CIK 0001331860 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.